Stay updated on Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Sign up to get notified when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.

Latest updates to the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page
- Check2 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing v3.5.4, indicating a minor revision of the record metadata.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a CMS/backend update. There is no apparent change to the study content or data presented on the page.SummaryDifference0.1%

- Check44 days agoChange DetectedUpdates the ClinicalTrials.gov page revision/version from **v3.5.2** to **v3.5.3**, reflecting a site release change rather than a change to the study details.SummaryDifference0.1%

- Check52 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision entry 'Revision: v3.5.0' appears and the previous 'Revision: v3.4.3' entry is removed.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page metadata now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Aviptadil for COVID-19 in High-Risk: Clinical Trial page.